152 related articles for article (PubMed ID: 18460899)
41. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838
[TBL] [Abstract][Full Text] [Related]
42. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG
PLoS One; 2012; 7(11):e49350. PubMed ID: 23139842
[TBL] [Abstract][Full Text] [Related]
43. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
44. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
45. Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice.
Pereira JA; Taniguti AP; Matsumura C; Marques MJ; Neto HS
Muscle Nerve; 2012 Sep; 46(3):400-6. PubMed ID: 22907231
[TBL] [Abstract][Full Text] [Related]
46. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
47. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
48. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
Moraes LH; Bollineli RC; Mizobuti DS; Silveira Ldos R; Marques MJ; Minatel E
Redox Rep; 2015 May; 20(3):109-15. PubMed ID: 25361473
[TBL] [Abstract][Full Text] [Related]
49. Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.
Wu MP; Gussoni E
Muscle Nerve; 2011 Jan; 43(1):88-93. PubMed ID: 21171099
[TBL] [Abstract][Full Text] [Related]
50. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.
Vianello S; Yu H; Voisin V; Haddad H; He X; Foutz AS; Sebrié C; Gillet B; Roulot M; Fougerousse F; Perronnet C; Vaillend C; Matecki S; Escolar D; Bossi L; Israël M; de la Porte S
FASEB J; 2013 Jun; 27(6):2256-69. PubMed ID: 23430975
[TBL] [Abstract][Full Text] [Related]
51. Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice.
Evans NP; Call JA; Bassaganya-Riera J; Robertson JL; Grange RW
Clin Nutr; 2010 Jun; 29(3):391-8. PubMed ID: 19897286
[TBL] [Abstract][Full Text] [Related]
52. Effect of nuclear factor κB inhibition on serotype 9 adeno-associated viral (AAV9) minidystrophin gene transfer to the mdx mouse.
Reay DP; Niizawa GA; Watchko JF; Daood M; Reay JC; Raggi E; Clemens PR
Mol Med; 2012 May; 18(1):466-76. PubMed ID: 22231732
[TBL] [Abstract][Full Text] [Related]
53. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
54. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice.
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H128-H140. PubMed ID: 27836895
[TBL] [Abstract][Full Text] [Related]
55. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
Anderson JE; Weber M; Vargas C
Cell Transplant; 2000; 9(4):551-64. PubMed ID: 11038071
[TBL] [Abstract][Full Text] [Related]
56. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
57. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
58. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
59. Paeonia lactiflora extract improves the muscle function of mdx mice, an animal model of Duchenne muscular dystrophy, via downregulating the high mobility group box 1 protein.
Sim I; Jang J; Song J; Lee J; Lim H; Lee HJ; Hwang G; Kwon YV; Lee D; Yoon Y
J Ethnopharmacol; 2022 May; 289():115079. PubMed ID: 35149132
[TBL] [Abstract][Full Text] [Related]
60. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.
Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ
J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
